World Conference on Oncology & Cancer Care (WCOCC-2026)

  Synthetic Lethality in Cancer Therapy: Revolutionizing Precision Oncology Through Targeted Genetic Vulnerabilities Cancer treatment has entered a new era where therapies are increasingly designed to target the unique genetic characteristics of individual tumors rather than relying solely on conventional chemotherapy or radiation. One of the most promising breakthroughs driving this transformation is synthetic lethality , an innovative precision oncology strategy that selectively destroys cancer cells by exploiting specific genetic weaknesses while minimizing damage to healthy tissues. The success of PARP inhibitors in patients with BRCA1 and BRCA2 mutations has demonstrated the tremendous clinical potential of synthetic lethality, inspiring researchers to discover new genetic interactions that can be translated into highly targeted cancer therapies. Today, advances in genomics , next-generation sequencing (NGS) , artificial intelligence , and precision medicine are accele...

  Meta Title: Ferroptosis in Cancer: A Novel Cell Death Pathway Transforming Future Cancer Therapy | WCOCC-2026 Meta Description Discover how ferroptosis is transforming cancer therapy through iron-dependent cell death, precision oncology, targeted treatments, and personalized cancer care. Introduction Ferroptosis in Cancer: A Novel Cell Death Pathway Transforming Future Cancer Therapy Cancer remains one of the leading causes of death worldwide, despite remarkable advances in early diagnosis, precision medicine, immunotherapy, and targeted treatments. While conventional therapies such as chemotherapy, radiotherapy, and surgery have significantly improved patient outcomes, many cancers eventually develop resistance, limiting the long-term effectiveness of these treatments. This challenge has driven researchers to explore innovative therapeutic strategies capable of overcoming drug resistance and improving survival rates. One of the most exciting breakthroughs in oncology...